phrykt

SkinHealth Systems Inc. (SKIN): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of SKIN were reported in the last 12 months. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling SkinHealth Systems

From the latest filings

Overall: more selling than buying. Funds and famous investors mostly sold.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns SKIN

96 funds and institutions reported SKIN shares worth $46.8M at the end of Q2 2026, about 53% of the company. The largest holder is Capricorn Fund Managers Ltd with 17.4%.

Funds and institutions (13F) 53%Everyone else 47%

10 largest owners, by share of the company

Capricorn Fund Managers Ltd17.4%
FMR LLC (Fidelity)8.0%
BlackRock, Inc.6.7%
Millennium Management LLC5.9%
Vanguard Capital Management LLC2.7%
Woodline Partners LP1.8%
Silver Point Capital L.P.1.2%
D. E. Shaw & Co., Inc.1.1%
Geode Capital Management, LLC0.8%
UBS Group AG0.7%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Capricorn Fund Managers Ltd22.28M17.43%$15.4M+15%
FMR LLC (Fidelity)10.20M7.98%$7.1M-41%
BlackRock, Inc.8.52M6.67%$5.9M+16%
Millennium Management LLC7.54M5.90%$5.2M+32%
Vanguard Capital Management LLC3.50M2.74%$2.4M+2%
Woodline Partners LP2.33M1.82%$1.6M-59%
Silver Point Capital L.P.1.59M1.25%$1.1MNo change
D. E. Shaw & Co., Inc.1.43M1.12%$992K-25%
Geode Capital Management, LLC960,3740.75%$665K-57%
UBS Group AG839,3830.66%$582K+249%
Squarepoint Ops LLC673,8090.53%$467K+125%
Glendon Capital Management LP636,9540.50%$441KNo change
Prescott Group Capital Management, L.L.C.577,7300.45%$400K-10%
Vanguard Fiduciary Trust Co497,2550.39%$345K-15%
AQR Capital Management LLC483,9080.38%$335K-3%
Charles Schwab Investment Management Inc410,3820.32%$284K-43%
Sixth Street Partners Management Company, L.P.410,3820.32%$284K–
GRIMES & Co WEALTH MANAGEMENT, LLC406,9870.32%$282KNo change
State Street Corp387,1500.30%$268K-79%
Renaissance Technologies LLC364,6910.29%$253K+29%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

No SKIN insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

SKIN short interest

Low short interest. 0.3% of SKIN shares are sold short: about 1 share in 363. Over the last 12 reports the number of shares short went down 98%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 358,652 SKIN shares were sold short, 0.3% of the shares outstanding, down 4.5% from the report before. At the average daily volume of 53,625 shares, buying them all back would take about 6.7 trading days (days to cover).

Shares short, % of all shares

0.28%May 15Oct 3014.6%

Days to cover

6.7May 15Oct 3027.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026358,6520.28%-5%53,6256.7
Oct 15, 2026375,6550.29%-95%26,34614.3
Sep 30, 20267.25M5.57%+1%333,09821.8
Sep 15, 20267.18M5.52%-0%295,76324.3
Aug 31, 20267.20M5.53%+2%412,81117.4
Aug 14, 20267.07M5.43%-7%419,85116.8
Jul 31, 20267.59M5.94%-13%822,3019.2
Jul 15, 20268.75M6.85%-10%10.33M1.0
Jun 30, 20269.74M7.63%-22%2.07M4.7
Jun 15, 202612.46M9.75%-11%630,19719.8
May 29, 202614.06M11.00%-13%1.52M9.3
May 15, 202616.25M12.72%-2%1.67M9.7

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

SkinHealth Systems company events

SkinHealth Systems filed 16 reports on Form 8-K in the last 12 months, 6 of them about an important change (leadership, listing). The latest was on Nov 5, 2026.

  1. Nov 5, 2026ResultsReleased financial results. Filing
  2. Oct 14, 2026SharesChanged the rights of its shareholders. Filing
  3. Oct 6, 2026AgreementEnded an important agreement. Filing
  4. Sep 28, 2026VoteReported shareholder vote results. Filing
  5. Sep 10, 2026LeadershipThe Board of Directors of SkinHealth Systems Inc. promoted its Chief Financial Officer, Michael Monahan, to Chief Financial and Operating Officer. Filing
  6. Aug 14, 2026LeadershipSheri Lewis notified SkinHealth Systems Inc. of her decision to resign as its Chief Operations, Quality and Technology Officer to pursue other business opportunities outside of the Company. Filing
  7. Aug 6, 2026ResultsReleased financial results. Filing
  8. Jun 22, 2026AnnouncementSkinHealth Systems Inc., f/k/a The Beauty Health Company, entered into a Stipulation and Agreement of Settlement to settle the securities class action pending in the United States District Court for the Central District of California, captioned Alghazwi v. Filing
  9. Jun 16, 2026VoteReported shareholder vote results. Filing
  10. May 21, 2026LeadershipAmended an earlier report. Of the Original Form 8-K, including the provision of the executed Severance and General Release Agreement entered into by and among Hydrafacial LLC, SkinHealth Systems Inc., and Mr. Menezes. Filing
  11. May 12, 2026ListingSkinHealth Systems Inc., a Delaware corporation, received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that the listing of its Class A Common Stock, par value $0.0001 per share, was not in compliance with Nasdaq Listing Rule… Filing
  12. May 7, 2026ResultsReleased financial results. Filing
  13. May 6, 2026LeadershipThe Board of Directors of SkinHealth Systems Inc. terminated Mr. Ronald Menezes' employment as Chief Revenue Officer of the Company without cause, effective as of May 5, 2026. Filing
  14. Apr 22, 2026LeadershipAt the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors of The Beauty Health Company, the Board appointed Mr. Kenneth Tripp to fill the single vacancy on the Board effective as of April 17, 2026, increased the number of members of the Board from nine (9)… Filing
  15. Mar 12, 2026ResultsReleased financial results. Filing
  16. Mar 6, 2026AnnouncementThe Beauty Health Company gave notice to its stockholders of record as of February 20, 2026, that on February 9, 2026, the parties to the consolidated stockholder derivative action pending in the Delaware Court of Chancery, captioned Elstein v. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

SkinHealth Systems financials

Famous investors that hold SKIN

4 of the 50 well-known investors we track reported holding SKIN in their latest 13F filing. The largest position is Israel Englander's, worth $3.2M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 20265.02M$3.2M0.0%-33%
Jim Simons · Renaissance TechnologiesQ3 2026442,991$279K0.0%+21%
Paul Tudor Jones · Tudor Investment CorpQ3 2026301,277$190K0.0%No change
Ken Griffin · Citadel AdvisorsQ3 2026120,970$76.2K0.0%-29%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named SKIN in the last 120 days.

FiledHolderFormStake
Nov 9, 2026Integrated Core Strategies (US) LLC13G/A3.8%
Nov 9, 2026Integrated Core Strategies (US) LLC13G/A3.8%
Nov 5, 2026FMR LLC13G/A4.2%
Nov 5, 2026FMR LLC13G/A4.2%

Questions about SkinHealth Systems Inc. (SKIN) stock

Who owns the most SKIN stock?

The largest reported owner of SkinHealth Systems Inc. (SKIN) is Capricorn Fund Managers Ltd, with 17.4% of the company. In total, 96 funds and institutions reported holding SKIN at the end of Q2 2026, together about 53% of the shares. See the largest owners.

Are SKIN insiders buying or selling?

No SKIN insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in SKIN?

As of Oct 30, 2026, 358,652 SKIN shares were sold short, 0.3% of the shares outstanding, down 4.5% from the report before. At the average daily volume of 53,625 shares, buying them all back would take about 6.7 trading days (days to cover). See the history.

Which famous investors hold SKIN?

4 of the 50 well-known investors we track reported SKIN in their latest 13F filing, including Israel Englander, Jim Simons, Paul Tudor Jones. The largest position is worth $3.2M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.